Enhanced NRF1-mediated proteasome bounce-back and nelfinavir-mediated bortezomib sensitization in gemcitabine/cisplatin-resistant bladder cancer cells.
- DOI
- 10.1016/j.bbrc.2026.154629
- Published
- 2026 Sep 23
- Container
- Biochemical and biophysical research communications
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbrc.2026.154629,
title = {Enhanced NRF1-mediated proteasome bounce-back and nelfinavir-mediated bortezomib sensitization in gemcitabine/cisplatin-resistant bladder cancer cells.},
author = {Ota A and Kawai M and Himura R and Maruyama S and Saka T and Yoshino Y and Yamada G and Tsujita T and Ikari A and Endo S},
year = {2026},
journal = {Biochemical and biophysical research communications},
doi = {10.1016/j.bbrc.2026.154629},
url = {https://doi.org/10.1016/j.bbrc.2026.154629}
}RIS
TY - JOUR TI - Enhanced NRF1-mediated proteasome bounce-back and nelfinavir-mediated bortezomib sensitization in gemcitabine/cisplatin-resistant bladder cancer cells. AU - Ota A AU - Kawai M AU - Himura R AU - Maruyama S AU - Saka T AU - Yoshino Y AU - Yamada G AU - Tsujita T AU - Ikari A AU - Endo S PY - 2026 JO - Biochemical and biophysical research communications DO - 10.1016/j.bbrc.2026.154629 UR - https://doi.org/10.1016/j.bbrc.2026.154629 ER -
APA
A, O., M, K., R, H., S, M., T, S., Y, Y., G, Y., T, T., A, I., & S, E. (2026). Enhanced NRF1-mediated proteasome bounce-back and nelfinavir-mediated bortezomib sensitization in gemcitabine/cisplatin-resistant bladder cancer cells.. Biochemical and biophysical research communications. https://doi.org/10.1016/j.bbrc.2026.154629
Source records
- pubmed · retrieved 2026-09-26T06:07:57.871Z